Company intelligence / Profile preview

BioMeat Foodtech

Petah Tikva, Israel

Ownership: Private
Employees: ~2
Development stage: Other

Overview

BioMeat Foodtech is a publicly traded Israeli investment fund specializing in growth capital for R&D stage companies focused on food technology, particularly in meat substitutes and alternative proteins. It does not itself conduct drug development or clinical trials, and thus does not have clinical results or a therapeutic pipeline as a biotech/pharma would.

Industry: Investors

Partnerships

Solbar Food Technologies

Beyond the preview

Go deeper on BioMeat Foodtech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioMeat Foodtech.

Explore the full profile